ATE1237T1 - Hypotensiv wirksamer 2,6dimethyl-4-(2,3-dichlorop henyl)-1,4-dihydropyridin - Google Patents

Hypotensiv wirksamer 2,6dimethyl-4-(2,3-dichlorop henyl)-1,4-dihydropyridin

Info

Publication number
ATE1237T1
ATE1237T1 AT79850057T AT79850057T ATE1237T1 AT E1237 T1 ATE1237 T1 AT E1237T1 AT 79850057 T AT79850057 T AT 79850057T AT 79850057 T AT79850057 T AT 79850057T AT E1237 T1 ATE1237 T1 AT E1237T1
Authority
AT
Austria
Prior art keywords
sub
sup
och
group
6dimethyl
Prior art date
Application number
AT79850057T
Other languages
English (en)
Inventor
Peter Bernhard Berntsson
Stig Ake Ingemar Carlsson
Jan Oernulf Gaarder
Bengt Richard Ljung
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20335348&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE1237(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of ATE1237T1 publication Critical patent/ATE1237T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
AT79850057T 1978-06-30 1979-06-12 Hypotensiv wirksamer 2,6dimethyl-4-(2,3-dichlorop henyl)-1,4-dihydropyridin ATE1237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7807404A SE429652B (sv) 1978-06-30 1978-06-30 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
EP79850057A EP0007293B1 (de) 1978-06-30 1979-06-12 Hypotensiv wirksamer 2,6-Dimethyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridin-3,5-dicarbonsäure-3-methylester-5-ethylester, Verfahren zu seiner Herstellung und diesen enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE1237T1 true ATE1237T1 (de) 1982-07-15

Family

ID=20335348

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79850057T ATE1237T1 (de) 1978-06-30 1979-06-12 Hypotensiv wirksamer 2,6dimethyl-4-(2,3-dichlorop henyl)-1,4-dihydropyridin

Country Status (24)

Country Link
US (1) US4264611A (de)
EP (1) EP0007293B1 (de)
JP (1) JPS559083A (de)
AT (1) ATE1237T1 (de)
AU (1) AU529116B2 (de)
BG (1) BG61420B2 (de)
CA (1) CA1117530A (de)
CS (1) CS241021B2 (de)
CY (1) CY1299A (de)
DD (1) DD144667A5 (de)
DE (1) DE2963150D1 (de)
DK (1) DK148978C (de)
FI (1) FI70573C (de)
HK (1) HK60585A (de)
HU (1) HU178568B (de)
IE (1) IE48650B1 (de)
LU (2) LU88666I2 (de)
NL (2) NL930054I2 (de)
NO (3) NO151965C (de)
NZ (1) NZ190809A (de)
SE (1) SE429652B (de)
SG (1) SG26085G (de)
SU (2) SU856380A3 (de)
ZA (1) ZA792804B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
AU561213B2 (en) * 1983-06-02 1987-04-30 Teijin Limited 1, 4-dihydropyridine derivative
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
FI852359L (fi) * 1984-06-27 1985-12-28 Hoffmann La Roche Dihydropyridinderivat.
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
DE3447170A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
NZ220022A (en) * 1986-04-22 1990-04-26 Byk Gulden Lomberg Chem Fab 1,4-dihydropyridine derivatives and pharmaceutical compositions
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
JPS63255071A (ja) * 1987-04-14 1988-10-21 株式会社　岡田吾作郎商店 磁石内蔵健康棒
AT391269B (de) * 1988-12-30 1990-09-10 Burghart Kurt Pharmazeutische zubereitung
US5310917A (en) * 1991-09-13 1994-05-10 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropydrines
AU3245493A (en) * 1991-12-02 1993-06-28 Sepracor, Inc. Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
ATE234286T1 (de) * 1993-12-10 2003-03-15 Bayer Ag Phenyl-substituierte 1,4-dihydropyridine mit cerebraler aktivität
DE4430639A1 (de) * 1994-08-29 1996-03-07 Bayer Ag Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5977369A (en) * 1995-12-28 1999-11-02 Napp Technologies, Inc. Process to prepare dihydropyridine and derivatives thereof
SE9600086D0 (sv) * 1996-01-10 1996-01-10 Astra Ab New manufacturing process
IT1283793B1 (it) * 1996-08-23 1998-04-30 Lusochimica Spa Processo per la preparazione di diidropiridine
AU8430098A (en) * 1998-07-23 2000-02-14 Ing-Jun Chen Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6569456B2 (en) 2000-01-13 2003-05-27 Osmotica Corp. Osmotic device containing diltiazem and an ACE inhibitor or diuretic
NZ521853A (en) * 2000-04-11 2003-11-28 Sankyo Co Stabilized pharmaceutical compositions containing a calcium blocker
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
AP1963A (en) * 2003-05-30 2009-03-03 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
WO2006014930A2 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7893050B2 (en) * 2005-10-26 2011-02-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (de) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Kombinationstherapie mit Fasudil zur Behandlung von pulmonaler Hypertonie
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
US8748648B2 (en) * 2007-09-06 2014-06-10 Nektar Therapeutics Oligomer-calcium channel blocker conjugates
US20090118258A1 (en) * 2007-11-07 2009-05-07 Bruce Damiano Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
WO2012123966A1 (en) 2011-03-04 2012-09-20 Arch Pharmalabs Limited Process for the preparation of 4 -substituted -1, 4-dihydropyridines
CN102827068A (zh) * 2011-06-17 2012-12-19 张锐豪 一种4-(2, 3-二氯苯基)-2, 6-二甲基-1, 4-二氢-5-甲氧基羰基-3-吡啶羧酸的制备方法
RU2570752C2 (ru) 2011-08-26 2015-12-10 Вокхардт Лимитед Способы лечения сердечно-сосудистых нарушений
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
CN104177286A (zh) * 2014-08-11 2014-12-03 广东东阳光药业有限公司 一种地平类药物的制备方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
KR101824982B1 (ko) 2015-10-07 2018-02-02 엘지전자 주식회사 차량 및 그 제어방법
CN107952483B (zh) * 2017-12-18 2020-07-28 万华化学集团股份有限公司 一种催化剂，使用该催化剂的反应器，以及一种制备β-苯乙醇的方法
CN108840819B (zh) * 2018-04-02 2021-07-30 常州瑞明药业有限公司 一种非洛地平的制备方法
JP7470647B2 (ja) 2018-06-14 2024-04-18 アストラゼネカ・ユーケイ・リミテッド ジヒドロピリジン型カルシウムチャネル遮断薬医薬組成物を用いて血圧を低下させるための方法
PL3911648T3 (pl) 2019-01-18 2025-03-10 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksy)-2- pirymidynylo]amino]cyklopentylo]amino][1(2h),3'-bipirydyn]-2-on jako inhibitor pcsk9 i sposoby jego zastosowania

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
BG61420B2 (bg) 1997-07-31
NZ190809A (en) 1982-03-09
HK60585A (en) 1985-08-23
DK148978C (da) 1986-08-18
EP0007293A1 (de) 1980-01-23
HU178568B (en) 1982-05-28
DK148978B (da) 1985-12-09
EP0007293B1 (de) 1982-06-23
SG26085G (en) 1986-01-24
US4264611A (en) 1981-04-28
IE48650B1 (en) 1985-04-03
NL930054I1 (nl) 1993-09-01
US4264611B1 (de) 1984-07-17
SU915799A3 (en) 1982-03-23
ZA792804B (en) 1980-06-25
NO1994026I1 (no) 1994-12-21
AU4831679A (en) 1980-02-07
NO1996006I1 (no) 1996-06-24
FI792058A7 (fi) 1979-12-31
JPS559083A (en) 1980-01-22
AU529116B2 (en) 1983-05-26
CY1299A (en) 1985-10-18
IE791217L (en) 1979-12-30
SU856380A3 (ru) 1981-08-15
NO151965C (no) 1985-07-10
SE7807404L (sv) 1979-12-31
NL930054I2 (nl) 1994-02-16
LU88666I2 (fr) 1996-02-01
DE2963150D1 (en) 1982-08-12
FI70573C (fi) 1986-09-24
JPS6121550B2 (de) 1986-05-27
LU88306I2 (fr) 1994-05-04
CA1117530A (en) 1982-02-02
FI70573B (fi) 1986-06-06
NO151965B (no) 1985-04-01
NO792112L (no) 1980-01-03
SE429652B (sv) 1983-09-19
DD144667A5 (de) 1980-10-29
NL940012I1 (nl) 1994-08-01
CS241021B2 (en) 1986-03-13
DK275079A (da) 1979-12-31

Similar Documents

Publication Publication Date Title
ATE1237T1 (de) Hypotensiv wirksamer 2,6dimethyl-4-(2,3-dichlorop henyl)-1,4-dihydropyridin
FR2430938A1 (fr) Nouvelles oxybenzylidenes bornanones, leur procede de preparation, et compositions cosmetiques les contenant
DK159148C (da) Analogifremgangsmaade til fremstilling af tranexamsyrederivater
OA06889A (fr) Nouveaux dérivés du 4H-1,2,4-triazole, leur préparation, leur application comme médicament, les compositions les renfermant et les intermédiaires obtenus.
FI821583A0 (fi) Nya 1-pyrrolintiolaktimetrar och foerfarande foer deras framstaellning
FI821504A0 (fi) Aminocyklopentanolsyror och -estrar och deras framstaellning och farmaceutiska komposition
SE8701524D0 (sv) Nya sulfonamider och deras framstellningsforfarande
FI833025A0 (fi) Substituerade 1,3,4-benzotriazepiner, foerfarande foer deras framstaellning och deras anvaendning slaekemedel
JPS5233627A (en) Preparation of novel o,o-dialkyl-o-(n-alkoxy-halogeno-acycimidoyl) pho sphates or thionophosphates
JPS5227781A (en) Preparation of 2;3'-riboepithiouridines
FR2432505A1 (fr) Nouveaux sels de 5-iodo-3-nitro-4-hydroxybenzonitrile, leur preparation et compositions qui les contiennent
JPS5414987A (en) Novel s-triazine compounds and its preparation
JPS5473751A (en) Phenyl ethanolamine derivatives and their preparation
JPS5271447A (en) Synthesis of 2,3-epoxycyclopentanone derivatives
JPS53124276A (en) Uracil derivatives
JPS5227780A (en) Preparation of 2;3'-lixoepithiouridine